Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Caplin Point Labs subsidiary gets US FDA nod for Ephedrine Sulfate Injection

Caplin Point Laboratories said that its subsidiary Caplin Steriles has been granted final approval from the United States Food and Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Ephedrine Sulfate Injection.

By: business-standard.com

Jul 19 2024
0
0 Views

Caplin Point Labs subsidiary gets US FDA nod for Ephedrine Sulfate Injection

Caplin Point Labs subsidiary gets US FDA nod for Ephedrine Sulfate Injection

Related

South Indian Bank climbs after Q1 PAT jumps 45% YoY to Rs 294 cr

Volumes jump at Tata Teleservices (Maharashtra) Ltd counter

Caplin Point Labs subsidiary gets US FDA nod for Ephedrine Sulfate Injection

K.P. Energy update on 250.8 MW wind power project at Sidhpur site

Broad flare-up in vegetable prices concerns overall disinflation that had been underway: RBI Bulletin

Gravita India announces closure of its step-down subsidiary in Costa Rica

Dee Development bags supply order from BHEL worth over Rs 6 crore

Nifty MidCap, SmallCap indices break 20-DMA support; can fall another 9%

Strong Capital Inflows Support Rupee, Says RBI

Caplin Steriles receives USFDA approval for Ephedrine Sulfate injection

Sensex slides 337 pts; oil & gas shares decline

One 97 Communications reports consolidated net loss of Rs 838.90 crore in the June 2024 quarter

South Indian Bank climbs after Q1 PAT jumps 45% YoY to Rs 294 cr